-
2 months ago | 
dx.doi.org | Da Hsuan Feng |Li Guo |Yihan Zhao |Fang Yuan
-
2 months ago | 
pubs.acs.org | Da Hsuan Feng |Li Guo |Yihan Zhao |Fang Yuan
-
Dec 24, 2024 | 
mdpi.com | Li Guo
4. Experimental Verification and AnalysisThe methods proposed in this paper have been implemented with C# programming language in conjunction with ArcEngine component library. This implementation enables the realization of change detection and incremental topological consistency updates for road networks. To validate the effectiveness of these proposed methods, various experimental tests have been conducted on the production practice of MapWorld data fusion.
-
Dec 18, 2024 | 
mdpi.com | Li Guo
Open AccessArticle by Bo Pei 1, Xin Qiao 1, Que Huang 2,3,4,5, Changcheng Liu 2,3, Mengna Shi 2,3, Xiaomei Jiang 6, Feng Li 1,* and Li Guo 2,3,4,* 1 Wuhan Institute of Marine Electric Propulsion, Wuhan 430064, China 2 School of Environment and Safety Engineering, North University of China, Taiyuan 030051, China 3 Institute of Advanced Energy Materials and Systems, North University of China, Taiyuan 030051, China 4 Shanxi Key Laboratory of Efficient Hydrogen Storage & Production Technology and...
-
Dec 17, 2024 | 
mdpi.com | Li Guo
Open AccessEditorial by Weiwei Chen Prof. Weiwei Chen is a Supervisor at the Northeast Institute of Geography and Agroecology, Chinese [...] Prof. Weiwei Chen is a Supervisor at the Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences.
-
Sep 16, 2024 | 
natlawreview.com | Li Guo
This Federal Circuit opinion addresses a district court’s decision granting plaintiff’s motion for a preliminary injunction.[1]BackgroundPlaintiff Natera, Inc. (“Natera”) and defendant NeoGenomics Laboratories, Inc. (“NeoGenomics”) are research focused healthcare companies operating in the oncology testing industry. Both companies manufacture products used for early detection of cancer relapse.
-
Sep 16, 2024 | 
lexology.com | Li Guo
This Federal Circuit opinion addresses a district court’s decision granting plaintiff’s motion for a preliminary injunction.[1]BackgroundPlaintiff Natera, Inc. (“Natera”) and defendant NeoGenomics Laboratories, Inc. (“NeoGenomics”) are research focused healthcare companies operating in the oncology testing industry. Both companies manufacture products used for early detection of cancer relapse.
-
Sep 7, 2024 | 
biorxiv.org | Andras Nagy |Li Guo |Pascal Duchesneau |Evan Sawula
AbstractHere, we present a combination of cell and gene therapy that harnesses the regenerative properties of GDF11 in age-related pulmonary fibrosis. Our genome-edited FailSafeTM-GDF11 mouse ESC line provides controlled proliferation and efficient derivation to lung progenitors while inducibly expressing GDF11. When these cells were transplanted into bleomycin-injured aged mice, they acted as a source of reparative cells, restoring the damaged alveolar epithelium.
-
Jul 9, 2024 | 
jdsupra.com | Li Guo
In Intellectual Tech v. Zebra Technologies 2022-2207 (Fed. Cir. May 1, 2024), this decision addresses a district court’s determination that the patent owner plaintiff lacked constitutional standing because it was divested of all exclusionary rights over the patent at issue upon default.
-
Jul 8, 2024 | 
natlawreview.com | Li Guo
In Intellectual Tech v. Zebra Technologies 2022-2207 (Fed. Cir. May 1, 2024), the Federal Circuit addressed a district court’s determination that the patent owner plaintiff lacked constitutional standing because it was divested of all exclusionary rights over the patent at issue upon default.
